These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19821997)

  • 1. Antiretroviral treatment adherence and its determinants in Sub-Saharan Africa: a prospective study at Yaounde Central Hospital, Cameroon.
    Rougemont M; Stoll BE; Elia N; Ngang P
    AIDS Res Ther; 2009 Oct; 6():21. PubMed ID: 19821997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to Antiretroviral Therapy (ART) in Yaoundé-Cameroon: Association with Opportunistic Infections, Depression, ART Regimen and Side Effects.
    Fonsah JY; Njamnshi AK; Kouanfack C; Qiu F; Njamnshi DM; Tagny CT; Nchindap E; Kenmogne L; Mbanya D; Heaton R; Kanmogne GD
    PLoS One; 2017; 12(1):e0170893. PubMed ID: 28141867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short term adherence tool predicts failure on second line protease inhibitor-based antiretroviral therapy: an observational cohort study.
    Court R; Leisegang R; Stewart A; Sunpath H; Murphy R; Winternheimer P; Ally M; Maartens G
    BMC Infect Dis; 2014 Dec; 14():664. PubMed ID: 25472544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to On-Time ART Drug Pick-Up and Its Association with CD4 Changes and Clinical Outcomes Amongst HIV Infected Adults on First-Line Antiretroviral Therapy in Nigerian Hospitals.
    Anoje C; Agu KA; Oladele EA; Badru T; Adedokun O; Oqua D; Khamofu H; Adebayo O; Torpey K; Chabikuli ON
    AIDS Behav; 2017 Feb; 21(2):386-392. PubMed ID: 27388161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings.
    Sangeda RZ; Mosha F; Prosperi M; Aboud S; Vercauteren J; Camacho RJ; Lyamuya EF; Van Wijngaerden E; Vandamme AM
    BMC Public Health; 2014 Oct; 14():1035. PubMed ID: 25280535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: a cohort study.
    Fielding KL; Charalambous S; Stenson AL; Pemba LF; Martin DJ; Wood R; Churchyard GJ; Grant AD
    BMC Infect Dis; 2008 Jul; 8():93. PubMed ID: 18631397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.
    Bijker R; Jiamsakul A; Kityo C; Kiertiburanakul S; Siwale M; Phanuphak P; Akanmu S; Chaiwarith R; Wit FW; Sim BL; Boender TS; Ditangco R; Rinke De Wit TF; Sohn AH; Hamers RL
    J Int AIDS Soc; 2017 Mar; 20(1):21218. PubMed ID: 28362063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using a composite adherence tool to assess ART response and risk factors of poor adherence in pregnant and breastfeeding HIV-positive Cameroonian women at 6 and 12 months after initiating option B.
    Atanga PN; Ndetan HT; Fon PN; Meriki HD; Muffih TP; Achidi EA; Hoelscher M; Kroidl A
    BMC Pregnancy Childbirth; 2018 Oct; 18(1):418. PubMed ID: 30359239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.
    De Luca A; Marazzi MC; Mancinelli S; Ceffa S; Altan AM; Buonomo E; Prosperi MC; Pedruzzi B; Noorjehan AM; Scarcella P; Liotta G; Palombi L
    J Acquir Immune Defic Syndr; 2012 Mar; 59(3):236-44. PubMed ID: 22327246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon .
    Zoufaly A; Jochum J; Hammerl R; Nassimi N; Raymond Y; Burchard GD; Schmiedel S; Drexler JF; Campbell NK; Taka N; Awasom C; Metzner KJ; van Lunzen J; Feldt T
    J Antimicrob Chemother; 2015 Mar; 70(3):922-5. PubMed ID: 25428920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?
    Orrell C; Cohen K; Leisegang R; Bangsberg DR; Wood R; Maartens G
    AIDS Res Ther; 2017 Apr; 14(1):20. PubMed ID: 28376815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.
    Bisson GP; Gross R; Bellamy S; Chittams J; Hislop M; Regensberg L; Frank I; Maartens G; Nachega JB
    PLoS Med; 2008 May; 5(5):e109. PubMed ID: 18494555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.
    Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; de Wit J; Carr A;
    PLoS One; 2017; 12(4):e0174613. PubMed ID: 28369066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication-based Refill Adherence Among Pregnant Women Living With HIV in Nigeria.
    Omonaiye O; Nicholson P; Kusljic S; Mohebbi M; Manias E
    Clin Ther; 2020 Nov; 42(11):e209-e219. PubMed ID: 32951857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of periodontitis according to the immunological and virological profiles of HIV-infected patients in Yaoundé, Cameroon.
    Fokam J; Geh BKN; Sosso SM; Takou D; Ngufack ES; Nka AD; Bissek AZ; Eko DM; Ndjolo A
    BMC Oral Health; 2020 Dec; 20(1):359. PubMed ID: 33308188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring?
    Mekuria LA; Prins JM; Yalew AW; Sprangers MA; Nieuwkerk PT
    Trop Med Int Health; 2016 Jul; 21(7):856-69. PubMed ID: 27118068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study.
    Zoufaly A; Fillekes Q; Hammerl R; Nassimi N; Jochum J; Drexler JF; Awasom CN; Sunjoh F; Burchard GD; Burger DM; van Lunzen J; Feldt T
    Antivir Ther; 2013; 18(5):681-90. PubMed ID: 23502762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
    Townsend ML; Jackson GL; Smith R; Wilson KH
    Clin Ther; 2007 Apr; 29(4):711-6. PubMed ID: 17617294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational, randomised controlled trial.
    Gross R; Ritz J; Hughes MD; Salata R; Mugyenyi P; Hogg E; Wieclaw L; Godfrey C; Wallis CL; Mellors JW; Mudhune VO; Badal-Faesen S; Grinsztejn B; Collier AC
    Lancet Digit Health; 2019 May; 1(1):e26-e34. PubMed ID: 31528850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.